Patent · US Active

High concentration antibody and protein formulations

US8961964B2 · kind B2 · utility

39Cited by
35References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 21, 2011
Grant dateFeb 24, 2015
Priority date
Expiry dateJun 21, 2031

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S435/80
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application relates to highly concentrated antibody and protein formulations with reduced viscosity that are stable, relatively isotonic and are of low turbidity. The formulations are particularly suitable for subcutaneous administration. The application further describes articles of manufacture containing such formulations and method for using them to treat disorders treatable by the formulated antibody or protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.